ASPH is reported as a malignant factor in hepatocellular carcinoma, glioma, and pancreatic cancer46–48, and its targeting reduces proliferation and invasion of prostate cancer cells through Notch signalling modulation49. The gene discussed is ASPH; the disease is prostate carcinoma.